Complement activation and atherosclerosis

Molecular Immunology

Volumn 36, Issue 13-14, 1999, Pages 949-955

  Niculescu, Florin ^a   Rus, Horea ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Complement; Complement system; Endothelial cells; Smooth muscle cells; Terminal complement complex

Indexed keywords

JANUS KINASE;

ANIMAL CELL; ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; COMPLEMENT ACTIVATION; CONFERENCE PAPER; CYTOLYSIS; ENDOTHELIUM CELL; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE ACTIVATION;

ANIMALS; ARTERIES; ARTERIOSCLEROSIS; COMPLEMENT ACTIVATION; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOGLOBULINS; MODELS, BIOLOGICAL; MUSCLE, SMOOTH, VASCULAR; SIGNAL TRANSDUCTION;

EID: 0033393530     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00117-0     Document Type: Conference Paper

References (59)

1. Benzaquen L.R., Nicholson-Weller A., Halperin J.A. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J. Exp. Med. 179:1994;985-992.
2. Bhakdi S., Dorweiler B., Kirchmann R., Torzewski J., Weise E., Tranum-Jensen J., et al. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J. Exp. Med. 182:1995;1959-1971.
3. Carney D.F., Lang T.J., Shin M.L. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. J. Immunol. 145:1990;623-629.
4. Christiansen V.J., Sims P.J., Hamilton K.K. Complement C5b-9 increases plasminogen binding and activation on human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17:1997;164-171.
5. Foreman K.E., Vaporciyan A.A., Bonish B.K., Jones M.L., Johnson K.J., Glovsky M.M., et al. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94:1994;1147-1155.
6. Geertinger P., Sorensen H. Complement and atherosclerosis. Atherosclerosis. 18:1970;65-77.
7. Geertinger P., Sorensen H. On the reduced atherogenic effects of cholesterol feeding on rabbits with congenital complement (C6) deficency. Artery. 1:1977;177-184.
8. Halperin J.A., Taratusca A., Nicholson-Weller A. Terminal complement complex C5b-9 stimulate mitogenesis in 3T3 cells. J. Clin. Invest. 91:1993;1974-1978.
9. Hansson G.K., Holm J., Kral J.G. Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions. Acta Pathol. Microbiol. Immunol. Scand. 92:1984;429-435.
10. Hollander W., Colombo M.A., Kirkpatrick B., Paddock J. Soluble proteins in the human atherosclerotic plaque. With spectral reference to immunoglobulins, C3-complement component, alpha 1-antitrypsin and alpha 2-macroglobulin. Atherosclerosis. 34:1979;391-405.
11. Imagawa D.K., Osifchin N.E., Ramm L.E., Koga P.G., Hammer C.H., Shin H.S., et al. Release of arachidonic acid and formation of oxygenated derivatives after complement attack on macrophages: role of channel formation. J. Immunol. 136:1986;4637-4643.
12. Jackson C.L., Schwartz S.M. Pharmacology of smooth muscle cell replication. Hypertension. 20:1992;713-736.
13. Kilgore K.S., Schmid E., Shanley T.P., Flory C.M., Maheswari V., Tramontini N.L., et al. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am. J. Pathol. 150:1997;2019-2031.
14. Kilgore K.S., Shen J.P., Miller B.F., Ward P.A., Warren J.S. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J. Immunol. 155:1995;1434-1441.
15. Koski C.L., Ramm L.E., Hammer C.H., Mayer M.M., Shin M.L. Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics. Proc. Natl. Acad. Sci. USA. 80:1983;3816-3820.
16. Koyama H., Raines E.W., Bornfeldt K.E., Roberts J.M., Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell. 87:1996;1069-1078.
17. Kuvin T.J., Kimmelstiel C.D. Infectious causes of atherosclerosis. Amer. Heart J. 137:1999;216-226.
18. Mayer M.M. Mechanism of cytolysis by complement. Proc. Natl. Acad. Sci. USA. 69:1972;2954-2958.
19. Megran D.W., Stiver H.G., Bowie W.R. Complement activation and stimulation of chemotaxis by Chlamydia trachomatis. Infect. Immun. 49:1985;670-673.
20. Morgan B.P., Dankert J.R., Esser A.F. Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis. J. Immunol. 138:1987;246-253.
21. Morishita R., Gibbons G.H., Ellison K.E., Nakajima M., Zhang L., Kaneda Y., et al. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc. Natl. Acad. Sci. USA. 90:1993;8474-8478.
22. Morishita R., Gibbons G.H., Ellison K.E., Nakajima M., von der Leyen H., Zhang L., et al. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligo-nucleotides. J. Clin. Invest. 93:1994;1458-1464.
23. Niculescu F., Rus H.G., Vlaicu R. Immunohistochemical localization of C5b-9, S-protein, C3d, and apolipoprotein B in human arterial tissues with atherosclerosis. Atherosclerosis. 65:1987;1-11.
24. Niculescu F., Hugo F., Rus H.G., Vlaicu R., Bhakdi S. Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries. Clin. Exp. Immunol. 69:1987;477-483.
25. Niculescu F., Rus H.G., Porutiu D., Ghiurca V., Vlaicu R. Immunoelectron- microscopic localization of S-protein/vitronectin in human atherosclerotic wall. Atherosclerosis. 78:1989;197-203.
26. Niculescu F., Rus H.G., Vlaicu R. Decay-accelerating factor regulates complement mediated damage in human atherosclerotic wall. Immunol. Lett. 26:1990;17-23.
27. Niculescu F., Rus H., Shin S., Lang T., Shin M.L. Generation of diacylglycerol and ceramide during homologous complement activation. J. Immunol. 150:1993;214-224.
28. Niculescu F., Rus H., Shin M.L. Receptor-independent activation of guanine nucleotide-binding regulatory proteins by terminal-complement complexes. J. Biol. Chem. 269:1994;4417-4423.
29. Niculescu F., Rus H., Van Biesen T., Shin M.L. Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent. J. Immunol. 158:1997;4405-4412.
30. Niculescu F., Badea T., Rus H. Sublytic C5b-9 induces proliferation of aortic smooth muscle cells. Role of mitogen activated protein kinase and phosphatidylinositol 3-kinase. Atherosclerosis. 142:1999;47-56.
31. Niculescu F., Soane L., Badea T., Rus H., Shin M., Rus H.G. Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by C5b-9 complement complex in aortic endothelial cells. Immunopharmacol. 42:1999;187-193.
32. Orekhov A.N., Tertov V.V., Kabakov A.E., Adamova I. Yu, Pokrovsky S.N., Smirnov V.N. Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. Arterioscler. Thromb. 11:1991;316-326.
33. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:1995;487-517.
34. Parker T.G., Schneider M.D. Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype. Ann. Rev. Physiol. 53:1991;179-200.
35. Pinckard R.N., Olson M.S., Giclas P.C., Terry R., Boyer J.T., O'Rourke R.A. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J. Clin. Invest. 56:1975;740-750.
36. Reynolds G.D., Vance R.P. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch. Pathol. Lab. Med. 111:1987;265-269.
37. Ross R. Mechanisms of disease atherosclerosis an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
38. Rus H.G., Niculescu F., Constantinescu E., Cristea A., Vlaicu R. Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque. Atherosclerosis. 61:1986;35-42.
39. Rus H.G., Niculescu F., Porutiu D., Ghiurca V., Vlaicu R. Cells carrying C5b-9 complement complexes in human atherosclerotic wall. Immunol. Lett. 20:1989;305-310.
40. Rus H.G., Niculescu F., Shin M.L. Sublytic complement attack induces cell cycle in oligodendrocytes. S phase induction is dependent on c-jun activation. J. Immunol. 156:1996;4892-4990.
41. Rus H.G., Vlaicu R., Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis. 127:1996;263-271.
42. Schmiedt W., Kinscherf R., Deigner H.P., Kamencic H., Nauen O., Kilo J., et al. Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits. Arterioscler. Thromb. Vasc. Biol. 18:1998;1790-1795.
43. Seifert P.S., Hansson G.K. Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions. J. Clin. Invest. 84:1989;597-604.
44. Seifert P.S., Hansson G.K. Complement receptors and regulatory proteins in human atherosclerotic lesions. Arteriosclerosis. 9:1989;802-811.
45. Seifert P.S., Kazatchkine M.D. Generation of complement anaphylatoxins and C5b-9 by crystalline cholesterol oxidation derivatives depends on hydroxyl group number and position. Mol. Immunol. 24:1987;1303-1308.
46. Seifert P.S., Hugo F., Hansson G.K., Bhakdi S. Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. Lab. Invest. 60:1989;747-754.
47. Seifert P.S., Hugo F., Tranum-Jensen J., Zahringer U., Muhly M., Bhakdi S. Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions. J. Exp. Med. 172:1990;547-557.
48. Seifert P.S., Roth I., Schmiedt W., Oelert H., Okada N., Okada H., et al. CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions. Atherosclerosis. 96:1992;135-145.
49. Sherr C.J. G1 phase progression: cycling on cue. Cell. 79:1994;551-555.
50. Shin M.L., Rus H.G., Niculescu F.I. Membrane attack by complement: assembly and biology of terminal complement complexes. Lee A.G. Biomembranes. vol. 5:1996;119-146 JAI Press, Greenwich, CT.
51. Simionescu N., Vasile E., Lupu F., Popescu G., Simionescu M. Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am. J. Pathol. 123:1986;109-125.
52. Sims P.J., Wiedmer T. Induction of cellular procoagulant activity by the membrane attack complex of complement. Semin. Cell Biol. 6:1995;275-282.
53. Torzewski J., Oldroyd R., Lachmann P., Fitzsimmons C., Proudfoot D., Bowyer D. Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation. Arterioscler. Thromb. Vasc. Biol. 16:1996;673-677.
54. Torzewski M., Torzewski J., Bowyer D.E., Waltenberger J., Fitzsimmons C., Hombach V., et al. Immunohistochemical colocalization of the terminal complex of human complement and smooth muscle cell alpha-actin in early atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 17:1997;2448-2452.
55. Torzewski J., Torzewski M., Bowyer D.E., Frohlich M., Koenig W., Waltenberger J. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler. Thromb. Vasc. Biol. 18:1998;1386-1392.
56. Vlaicu R., Rus H.G., Niculescu F., Cristea A. Immunoglobulins and complement components in human aortic atherosclerotic intima. Atherosclerosis. 55:1985;35-50.
57. Vlaicu R., Niculescu F., Rus H.G., Cristea A. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Atherosclerosis. 57:1985;163-177.
58. 2+ initiated activation of cellular protein kinases. J. Biol. Chem. 262:1987;13,674-13,681.
59. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet. 344:1994;793-795.